Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesBecton Dickinson and Company

Becton Dickinson and Company

Healthcare Medical Instruments & Supplies
PortfolioPortfolio WatchlistWatchlist
Company price
197.945 USD -0.66 ( 0.33%)
Last update at 2026-11-03T20:59:00Z
VOLUME
1426324
Market Cap
50642.16M
P/E
31.62

Momentum Score

…

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company has a strategic collaboration with ChemoGLO for the advancement of hazardous drug contamination testing in health care

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
196.24
Low
199.17
High
52 Week Price Range
124.47
Low
191.94
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
198.60
Dividend Yield
2.29%
Revenue TTM
22484.00M
Revenue Per Share
79.76
Gross Profit TTM
10553.00M
Debt / Equity
0.76
ROE
6.61%
Net Debt
18330.00M
ROCE
5.31%
Diluted EPS TTM
5.88

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Type yearly yearly yearly yearly yearly
Date 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Income before tax 1882.00M 2005.00M 1662.00M 1783.00M 2242.00M
Net income 1678.00M 1705.00M 1484.00M 1779.00M 2092.00M
Selling general administrative 5278.00M 4857.00M 4719.00M 4709.00M 1.00M
Selling and marketing expenses - - - - 4867.00M
Gross profit 9924.00M 9125.00M 8170.00M 8477.00M 9427.00M
Reconciled depreciation 2462.00M 2286.00M 2288.00M 2229.00M 2273.00M
Ebit 2495.00M 2533.00M 2427.00M 2282.00M 2799.00M
Ebitda 4957.00M 4819.00M 4715.00M 4602.00M 5169.00M
Depreciation and amortization 2462.00M 2286.00M 2288.00M 2320.00M 2370.00M
Non operating income net other - - - -101.00M -88.00M
Operating income 2578.00M 2397.00M 2111.00M 2282.00M 2799.00M
Other operating expenses 19262.00M 17781.00M 16948.00M 16395.00M 17265.00M
Interest expense 613.00M 528.00M 452.00M 398.00M 469.00M
Tax provision 203.00M 300.00M 132.00M 148.00M 150.00M
Interest income 38.00M 163.00M 49.00M 16.00M 460.00M
Net interest income -575.00M -365.00M -403.00M -382.00M -460.00M
Extraordinary items 0.00M 0.00M -46.00M 144.00M 488.00M
Income tax expense 204.00M 300.00M 132.00M 148.00M 150.00M
Total revenue 21839.00M 20178.00M 19372.00M 18870.00M 20248.00M
Total operating expenses 7347.00M 6728.00M 5746.00M 6002.00M 6444.00M
Cost of revenue 11915.00M 11053.00M 11202.00M 10393.00M 10821.00M
Total other income expense net -696.00M -392.00M -359.00M -499.00M -557.00M
Discontinued operations - - - 144.00M 144.00M
Net income from continuing ops 1678.00M 1705.00M 1530.00M 1635.00M 2092.00M
Net income applicable to common shares 1678.00M 1705.00M 1424.00M 1689.00M 2002.00M
Preferred stock and other adjustments - - - 90.00M 90.00M
Breakdown 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Type yearly yearly yearly yearly yearly
Date 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Total assets 55325.00M 57286.00M 52780.00M 52934.00M 53866.00M
Intangible assets 2994.00M 10917.00M 552.00M 12311.00M 12784.00M
Other current assets 1508.00M 1291.00M 1380.00M 1712.00M 1071.00M
Total liab 29936.00M 31397.00M 26984.00M 27633.00M 30189.00M
Total stockholder equity 25390.00M 25911.00M 25796.00M 25301.00M 23677.00M
Other current liab 4779.00M 4722.00M 5500.00M 3933.00M 6126.00M
Common stock 371.00M 371.00M 371.00M 365.00M 365.00M
Capital stock 371.00M - - 367.00M 367.00M
Retained earnings 16622.00M 16139.00M 15535.00M 15157.00M 13826.00M
Other liab - - - 5936.00M 6453.00M
Good will 33023.00M 26465.00M 24522.00M 24621.00M 23901.00M
Other assets 2171.00M - 2078.00M 1.00M -1.00M
Cash 851.00M 1856.00M 1416.00M 1006.00M 2283.00M
Cash and equivalents 641.00M - 1416.00M 1006.00M 2283.00M
Total current liabilities 8313.00M 8956.00M 6641.00M 7811.00M 6626.00M
Current deferred revenue - - -1641.00M - -1793.00M
Net debt 18330.00M 18254.00M 14463.00M 15059.00M 15327.00M
Short term debt 1560.00M 2170.00M 1141.00M 2179.00M 500.00M
Short long term debt 1560.00M - 1141.00M 2179.00M 500.00M
Short long term debt total 19181.00M 20110.00M 15879.00M 16065.00M 17610.00M
Other stockholder equity 10292.00M 9401.00M 11438.00M 11265.00M 11572.00M
Property plant equipment 7882.00M - 6557.00M 6012.00M 6393.00M
Total current assets 9255.00M 10468.00M 8676.00M 8141.00M 8838.00M
Net tangible assets - - - -11631.00M -13007.00M
Short term investments 8.00M 445.00M 8.00M 8.00M 12.00M
Net receivables 2994.00M 3033.00M 2534.00M 2191.00M 2497.00M
Long term debt 17621.00M - 14738.00M 13886.00M 17110.00M
Inventory 3894.00M 3843.00M 3273.00M 3224.00M 2866.00M
Accounts payable 1974.00M 1896.00M 1641.00M 1699.00M 1793.00M
Accumulated other comprehensive income -1870.00M - -1548.00M -1488.00M -2088.00M
Common stock total equity - - - 365.00M 365.00M
Preferred stock total equity - - - 2.00M 2.00M
Retained earnings total equity - - - 15157.00M 13826.00M
Treasury stock - - - -8330.00M -7723.00M
Non currrent assets other 3056.00M 2615.00M 2078.00M -3361.00M 1952.00M
Non current assets total 46070.00M 46818.00M 44104.00M 44792.00M 45029.00M
Long term debt total 17621.00M - 14738.00M 13886.00M 17110.00M
Breakdown 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Type yearly yearly yearly yearly yearly
Date 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Investments -818.00M - -716.00M -3231.00M -1880.00M
Change to liabilities - - -517.00M -473.00M 687.00M
Total cashflows from investing activities -818.00M - -716.00M -3220.00M -1880.00M
Net borrowings -1334.00M - -723.00M -78.00M -243.00M
Total cash from financing activities -3617.00M 2087.00M -1957.00M -591.00M -3306.00M
Change to operating activities - - 192.00M -1394.00M 282.00M
Net income 1678.00M 1705.00M 1530.00M 1779.00M 2092.00M
Change in cash -1005.00M 375.00M 322.00M -1233.00M -525.00M
Begin period cash flow 1856.00M 1481.00M 1159.00M 2392.00M 2917.00M
End period cash flow 851.00M 1856.00M 1481.00M 1159.00M 2392.00M
Total cash from operating activities 3430.00M 3844.00M 2989.00M 2633.00M 4647.00M
Issuance of capital stock - - - 0.00M 0.00M
Depreciation 2462.00M 2286.00M 2288.00M 2229.00M 2273.00M
Other cashflows from investing activities -480.00M - 158.00M -177.00M -141.00M
Dividends paid 1196.00M 1100.00M 1114.00M 1082.00M 1048.00M
Change to inventory -410.00M 98.00M -15.00M -631.00M -104.00M
Change to account receivables 71.00M - -290.00M 32.00M -95.00M
Sale purchase of stock -1000.00M -500.00M 0.00M -500.00M -1750.00M
Other cashflows from financing activities -87.00M -88.00M 1312.00M 1796.00M -265.00M
Change to netincome - - -153.00M 155.00M -20.00M
Capital expenditures 760.00M 725.00M 874.00M 973.00M 1231.00M
Change receivables - - - 32.00M -95.00M
Cash flows other operating - - - 1180.00M -515.00M
Cash and cash equivalents changes - - - -1485.00M -539.00M
Change in working capital -800.00M - -828.00M -1394.00M 282.00M
Stock based compensation 258.00M 247.00M 259.00M 233.00M 237.00M
Other non cash items 306.00M -183.00M 362.00M -94.00M 67.00M
Free cash flow 2670.00M 3119.00M 2115.00M 1660.00M 3416.00M

Peer Comparison*

Sector: Healthcare Industry: Medical Instruments & Supplies

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
BDX
Becton Dickinson and Company		 -0.66
0.33%		 197.94 31.62 13.76 2.25 2.04 2.93 13.40
ISRG
Intuitive Surgical Inc		 3.88
0.89%		 440.75 43.30 31.35 12.25 7.35 11.63 30.22
ESLOF
EssilorLuxottica Société anonyme		 -2.00
0.95%		 208.00 44.84 27.62 4.07 2.49 3.71 16.04
ESLOY
Essilor International SA		 -1.89
1.80%		 103.04 41.68 27.25 3.94 2.45 3.71 16.04
HOCPF
HOYA Corporation		 -8.51
5.07%		 159.30 29.74 26.60 0.05 7.23 7.02 18.02

Profile*

Becton Dickinson and Company

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company has a strategic collaboration with ChemoGLO for the advancement of hazardous drug contamination testing in health care

1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880

201 847 6800

https://www.bd.com

72000

Name Title Year Born
Mr. Thomas E. Polen Jr. Pres, CEO & Chairman 1973
Mr. Christopher DelOrefice Exec. VP & CFO 1971
Mr. Samrat S. Khichi Esq. Exec. VP of Corp. Devel., Public Policy & Regulatory Affairs and Gen. Counsel 1967
Mr. Thomas J. Spoerel Sr. VP, Controller & Chief Accounting Officer 1978
Ms. Elizabeth McCombs Exec. VP & Chief Technology Officer 1976
Dr. Joseph M. Smith F.A.C.C, M.D., Ph.D. Sr. VP, Chief Scientific Officer & Co-Chair of Scientific Advisory Board NA
Ms. Denise Fleming Exec. VP of Technology & Global Services and Chief Information Officer NA
Ms. Francesca M. DeMartino Sr. VP & Head of Investor Relations NA
Michelle Quinn Sr. VP and Chief Ethics & Compliance Officer NA
Troy Kirkpatrick VP of PR NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

VNP
CAD 32.54
+24.44%
HUT
CAD 88.32
+14.81%
KEEL
CAD 3.05
+14.66%
MTY
CAD 36.63
+13.58%
CNL
CAD 15.98
+11.90%
MOON
CAD 4.72
-12.34%
EU
CAD 0.96
-8.57%
URE
CAD 1.02
-8.48%
AP-UN
CAD 3.71
-8.17%
HG
CAD 3.77
-8.05%

Equity Sectors*

  • Basic Materials

    -1.14%

  • Communication Services

    +0.65%

  • Consumer Cyclical

    +0.09%

  • Consumer Defensive

    -0.57%

  • Energy

    -0.15%

  • Financial Services

    +0.08%

  • Healthcare

    +2.18%

  • Industrials

    +2.04%

  • Real Estate

    -0.25%

  • Technology

    +1.02%

  • Utilities

    +0.66%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…